3D Medicines Inc. (1244.HK)

HKD 3.8

(7.04%)

Long Term Debt Summary of 3D Medicines Inc.

  • 3D Medicines Inc.'s latest annual long term debt in 2023 was 57.82 Million CNY , down -4.26% from previous year.
  • 3D Medicines Inc.'s latest quarterly long term debt in 2024 Q1 was 75.74 Million CNY , up 159.02% from previous quarter.
  • 3D Medicines Inc. reported annual long term debt of 60.4 Million CNY in 2022, up 31.34% from previous year.
  • 3D Medicines Inc. reported annual long term debt of 45.98 Million CNY in 2021, up 252.09% from previous year.
  • 3D Medicines Inc. reported quarterly long term debt of 75.74 Million CNY for 2024 Q1, up 159.02% from previous quarter.
  • 3D Medicines Inc. reported quarterly long term debt of 57.82 Million CNY for 2023 Q3, down -41.95% from previous quarter.

Annual Long Term Debt Chart of 3D Medicines Inc. (2023 - 2020)

Historical Annual Long Term Debt of 3D Medicines Inc. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 57.82 Million CNY -4.26%
2022 60.4 Million CNY 31.34%
2021 45.98 Million CNY 252.09%
2020 13.06 Million CNY 0.0%

Peer Long Term Debt Comparison of 3D Medicines Inc.

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -88.9%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 98.647%